Stay updated on Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe study record now shows the trial as Completed with recruitment closed and results posted. Key milestones, including primary completion date, study completion date, and total enrollment, have been updated.SummaryDifference4%

- Check8 days agoChange DetectedAdded navigation and help sections (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study) and updated the revision note to v3.6.0. The Intervention / Treatment header was removed.SummaryDifference0.5%

- Check15 days agoChange DetectedThe revision label on the page was updated from v3.5.4 to v3.5.5, signaling a new version of the document.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a newer release of the page. This reflects maintenance or packaging updates rather than changes to study content or functionality.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page’s footer revision/version label has been updated from v3.5.2 to v3.5.3, reflecting a minor technical site update rather than a change to the study information.SummaryDifference0.1%

- Check65 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial page.